Major Banks Invest $20 Million in BioCatch Series C

Israeli startup BioCatch announced on Wednesday the extension of its series C financing round by an additional $20 million invested by four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – to increase the round to a total of $168 million. BioCatch has so far raised $215 million in total, with its investors including venture capital firm Maverick Ventures. American Express Ventures, the strategic investment group of American Express, CreditEase, and Bain Capital.